Suppr超能文献

抗精神病药物对5-羟色胺-1A受体介导的前脉冲抑制破坏的差异效应。

Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition.

作者信息

van den Buuse Maarten, Gogos Andrea

机构信息

Behavioral Neuroscience Laboratory, The Mental Health Research Institute of Victoria, 155 Oak Street, Parkville, Victoria 3052, Australia.

出版信息

J Pharmacol Exp Ther. 2007 Mar;320(3):1224-36. doi: 10.1124/jpet.106.113084. Epub 2006 Dec 28.

Abstract

Serotonin-1A (5-HT(1A)) receptors have been implicated in the symptoms of schizophrenia. However, there is limited in vivo evidence for an interaction of antipsychotic drugs with 5-HT(1A) receptor-mediated behavioral effects. We therefore investigated in rats the action of several antipsychotic drugs on prepulse inhibition (PPI), a measure of sensorimotor gating that is deficient in schizophrenia. Disruption of PPI at the 100-ms interstimulus interval (ISI), but not the 30-ms ISI, was induced by treatment with 0.5 mg/kg 8-hydroxy-di-propylaminotetralin (8-OH-DPAT), the 5-HT(1A) receptor agonist. In rats pretreated with 0.25 mg/kg haloperidol (4-[-4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro butyrophenone) or raclopride [3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxybenzamide tartrate], the disruption of PPI was no longer significant. Of the atypical antipsychotic drugs clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine), olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine), risperidone [3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl) piperidino] ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one)], amisulpride (4-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-o-anisamide), and aripiprazole (7-[4-[-4[-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyrilor 7-[4-[4-(2,3-dichlorophenyl) piperazin-1-yl]butoxy]-1,2,3,4,-tetrahydroquinolin-2-one), only aripiprazole significantly reduced the effect of 8-OH-DPAT on PPI. This effect was mimicked by pretreatment with the 5-HT(1A) receptor partial agonist, buspirone [N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride]. On the other hand, some of the antipsychotic drugs and other pretreatments showed complex, prepulse-dependent effects on their own. These data show little in vivo interaction of several atypical antipsychotic drugs with the disruption of PPI mediated by 5-HT(1A) receptor stimulation. The action of haloperidol and raclopride suggests a major involvement of dopamine D(2) receptors in this effect, possibly downstream from the initial serotonergic stimulation. The action of aripiprazole could be mediated by its partial agonist properties at 5-HT(1A) receptors or its dopamine D(2)-blocking properties.

摘要

5-羟色胺-1A(5-HT(1A))受体与精神分裂症的症状有关。然而,抗精神病药物与5-HT(1A)受体介导的行为效应之间相互作用的体内证据有限。因此,我们在大鼠中研究了几种抗精神病药物对前脉冲抑制(PPI)的作用,PPI是一种感觉运动门控指标,在精神分裂症中存在缺陷。用5-HT(1A)受体激动剂0.5 mg/kg 8-羟基-二丙基氨基四氢萘(8-OH-DPAT)处理可诱导100毫秒刺激间隔(ISI)时的PPI破坏,但30毫秒ISI时则不会。在用0.25 mg/kg氟哌啶醇(4-[-4-(对氯苯基)-4-羟基哌啶基]-4'-氟丁酰苯)或雷氯必利[3,5-二氯-N-(1-乙基吡咯烷-2-基甲基)-2-羟基-6-甲氧基苯甲酰胺酒石酸盐]预处理的大鼠中,PPI的破坏不再显著。在非典型抗精神病药物氯氮平(8-氯-11-(4-甲基-1-哌嗪基)-5H-二苯并[b,e][1,4]-二氮杂卓)、奥氮平(2-甲基-4-(4-甲基-1-哌嗪基)-10H-噻吩并[2,3-b][1,5]苯并二氮杂卓)、利培酮[3-[2-[-4-(6-氟-1,2-苯并异恶唑-3-基)哌啶基]乙基-6,7,8,9-四氢-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮]、氨磺必利(4-氨基-N-[(1-乙基-2-吡咯烷基)甲基]-5-(乙磺酰基)-邻茴香酰胺)和阿立哌唑(7-[4-[-4[-(2,3-二氯苯基)-1-哌嗪基]丁氧基]-3,4-二氢咔唑醇或7-[4-[4-(2,3-二氯苯基)哌嗪-1-基]丁氧基]-1,2,3,4,-四氢喹啉-2-酮)中,只有阿立哌唑能显著降低8-OH-DPAT对PPI的作用。5-HT(1A)受体部分激动剂丁螺环酮[N-[4-[4-(2-嘧啶基)-1-哌嗪基]丁基]-8-氮杂螺[4.5]癸烷-7,9-二酮盐酸盐]预处理可模拟这种效应。另一方面,一些抗精神病药物和其他预处理自身显示出复杂的、依赖前脉冲的效应。这些数据表明几种非典型抗精神病药物与5-HT(1A)受体刺激介导的PPI破坏之间在体内几乎没有相互作用。氟哌啶醇和雷氯必利的作用表明多巴胺D(2)受体在这种效应中起主要作用,可能在最初的5-羟色胺能刺激的下游。阿立哌唑的作用可能由其在5-HT(1A)受体上的部分激动剂特性或其多巴胺D(2)阻断特性介导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验